Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 177-182

  Capurso, Cristiano ^a   Solfrizzi, Vincenzo ^b   Colacicco, Anna Maria ^b   D'Introno, Alessia ^b   Frisardi, Vincenza ^b   Imbimbo, Bruno P ^c   Lorusso, Maria ^b   Vendemiale, Gianluigi ^a,d   Denitto, Marta ^a   Santamato, Andrea ^a   Seripa, Davide ^e   Pilotto, Alberto ^e   Fiore, Pietro ^a   Capurso, Antonio ^b   Panza, Francesco ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Center for Aging Brain   (Italy)

^c Research and Development Department   (Italy)

^d IRCSS Casa Sollievo Dalla Sofferenza   (Italy)

^e Gerontology Geriatrics Research Laboratory   (Italy)

Author keywords

Alzheimer's disease; Chromosome 7; Dementia; IL 6 VNTR; IL 6 174 C G promoter

Indexed keywords

APOLIPOPROTEIN E4; INTERLEUKIN 6;

AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 7; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; ITALY; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 73649085771     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.10.022     Document Type: Article

References (47)

1. Abecasis G.R., Noguchi E., Heinzmann A., Traherne J.A., Bhattacharyya S., Leaves N.I., et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 68 (2001) 191-197
2. Altstiel L.D., and Sperber K. Cytokines in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 15 (1991) 481-495
3. Arosio B., Trabattoni D., Galimberti L., Bucciarelli P., Fasano F., Calabresi C., et al. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25 (2004) 1009-1015
4. Bagli M., Papassotiropoulos A., Knapp M., Jessen F., Rao M.L., Maier W., et al. Association between an interleukin-6 promoter and 30 flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 283 (2000) 109-112
5. Bagli M., Papassotiropoulos A., Hampel H., Becker K., Jessen F., Burger K., et al. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study. Eur Arch Psychiatry Clin Neurosci 253 (2003) 44-48
6. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the Alzgene database. Nature Genetics 39 (2007) 17-23 Accessed on September 20, 2009
7. Bohjak T.J., DeKosky S.T., Ganguli M., and Kamboh M.I. Genetic polymorphism in the Cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 288 (2000) 21-24
8. Bowcock A.M., Ray A., Erlich H., and Sehga P.B. Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. Nucleic Acids Res 17 (1989) 6855-6864
9. Campbell I.L., Stalder A.K., Chiang C.S., Bellinger R., Heyser C.J., Steffensen S., et al. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 2 (1997) 125-129
10. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Semeraro C., et al. Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp Gerontol 39 (2004) 1109-1114
11. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Capurso A., et al. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol 39 (2004) 1567-1573
12. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Semeraro C., et al. Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians. Ann Hum Genet 71 (2007) 843-848
13. Combarros O., Infante J., Llorca J., Peña N., Fernández-Viadero C., and Berciano J. Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk. J Neurol 252 (2005) 485-487
14. Combarros O., van Duijn C.M., Hammond N., Belbin O., Arias-Vásquez A., Cortina-Borja M., et al. Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J Neuroinflammation 22 (2009) 10.1186/1742-2094-6-22
15. Depboylu C., Lohmüller F., Gocke P., Du Y., Zimmer R., Gasser T., et al. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement Geriatr Cogn Disord 17 (2004) 170-173
16. Egensperger R., Kosel S., von Eitzen U., and Graeber M.B. Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol 8 (1998) 439-447
17. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 61 (2004) 668-672
18. Faltraco F., Burger K., Zill P., Teipel S.J., Moller H.-J., and Hampel H. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatrics Soc 51 (2003) 578-579
19. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
20. Folstein M.F., Folstein S.E., and McHugh P.R. «Mini-Mental State»: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
21. Fontalba A., Gutiérrez O., Llorca J., Mateo I., Vázquez-Higuera J.L., Berciano J., et al. Gene-gene interaction between CARD8 and interleukin-6 reduces Alzheimer's disease risk. J Neurol 256 (2009) 1184-1186
22. Gerdes L.U., Klausen I.C., Sihm I., and Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 9 (1992) 155-167
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
24. Hüll M., Strauss S., Berger M., Volk B., and Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 78 (1996) 37-41
25. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
26. Infante J., Sanz C., Fernández-Luna J.L., Llorca J., Berciano J., and Combarros O. Gene-gene interaction between interleukin-6 and interleukin-10 reduces AD risk. Neurology 63 (2004) 1135-1136
27. Katz S., and Akpom C.A. A measure of primary sociobiological functions. Int. J. Health Serv 6 (1976) 493-507
28. Koivisto A.M., Helisalmi S., Pihlajamäki J., Moilanen L., Kuusisto J., Laakso M., et al. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J Neurogenet 19 (2005) 155-161
29. Lawton M.P. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
30. Li H., Wetten S., Li L., St Jean P.L., Upmanyu R., Surh L., et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65 (2008) 45-53
31. Licastro F., Pedrini S., Ferri C., Casadei V., Govoni M., Pession A., et al. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 24 (2003) 921-926
32. Licastro F., Porcellini E., Caruso C., Lio D., and Corder E.H. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 28 (2007) 1637-1643
33. Loeb C., and Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 14 (1983) 399-401
34. Mateo I., Infante J., Rodríguez E., Berciano J., Combarros O., and Llorca J. Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk. J Neurol Neurosurg Psychiatry 77 (2006) 278-279
35. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
36. Murray R.E., McGuigan F., Grant S.F., Reid D.M., and Ralston S.H. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21 (1997) 89-92
37. Nishimura M., Sakamoto T., Kaji R., and Kawakami H. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci Lett 368 (2004) 140-143
38. Papassotiropoulos A., Bagli M., Jessen F., Bayer T.A., Maier W., and Rao M.L. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 45 (1999) 666-668
39. Panza F., Solfrizzi V., Torres F., Mastroianni F., Del Parigi A., Colacicco A.M., et al. Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 277 (1999) 53-56
40. Paradowski B., Celczyńska D., Dobosz T., and Noga L. Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease-preliminary report. Neurol Neurochir Pol 42 (2008) 312-315
41. Pola R., Flex A., Gaetani E., Lago A.D., Gerardino L., Pola P., et al. The -174 polymorphism of the interleukin-6 gene is associated with Alzheimer's disease in an Italian population. Neuroreport 13 (2002) 1645-1647
42. Ravaglia G., Paola F., Maioli F., Martelli M., Montesi F., Bastagli L., et al. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 41 (2006) 85-92
43. Shibata N., Ohnuma T., Takahashi T., Baba H., Ishizuka T., Ohtsuka M., et al. Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114 (2002) 436-439
44. Solfrizzi V., Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 72 (2002) 732-736
45. van Oijen M., Arp P.P., Jong F.J., Hofman A., Koudstaal P.J., Uitterlinden A.G., et al. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia: the Rotterdam study. Neurosci Lett 402 (2006) 113-117
46. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., and Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59 (2002) 371-378
47. Zhang Y., Hayes A., Pritchard A., Thaker U., Haque M.S., Lemmon H., et al. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci Lett 362 (2004) 99-102